Clinical Study
The Retrourethral Transobturator Sling Suspension in the Treatment of Male Urinary Stress Incontinence: Results of a Single Institution Experience
Table 3
Results of RTS treatment at maximum followup.
| Variable | Before sling implantation | After sling implantation |
| Daily pad use, pads/day | | | Median (range) | 4 (2–10) | 0 (0–10)† | Mean | 5.06 | 1.75 | ICIQ-UI SF score | | | Median (range) | 16 (7–21) | 4 (0–18)‡ | Mean | 15.39 | 5.65 | PVR*, mL | | | Median (range) | 0 (0–40) | 0 (0–70)§ | Mean | 7.33 | 11.00 | Maximum uroflowmetry, mL/s | | | Median (range) | 21.9 (2.3–53.6) | 17.2 (5.9–43.4)¶ | Mean | 23.97 | 20.33 |
|
|
*postvoid residual urine †U-Test; ‡U-Test; §U-Test; ¶U-Test; .
|